Pharma
Filter By: News | Articles | Products | Posters | White Papers | Videos | Podcasts | Application Notes | Journal Articles
New Global Atlas Maps This Wormy World
Aug 19 | News
Maps showing the distribution and prevalence of worm infections in every African country have been launched. These maps, called This Wormy World www.thiswormyworld.org, are the first of a series of Global Atlas of Helminth Infections which provide a unique, open-access, free information resource vital for planning and implementing deworming programs.
JDRF Launches Research Program
Aug 19 | News
JDRF announced another important step on the road to the development of an artificial pancreas – an automated system to better manage the blood sugar of people with type 1 diabetes – with the establishment of a research program to speed the development of faster-acting insulin
Merck KGaA Completes Millipore Acquisition
Aug 12 | Articles
Merck KGaA announced the successful completion of its acquisition of Millipore. The closing follows the approval of the acquisition by Millipore’s shareholders and the satisfaction of other customary conditions, including antitrust clearance in the United States and Europe
Caliper Awarded Additional Task Order
Aug 4 | Articles
Caliper Life Sciences, Inc. announced that its Caliper Discovery Alliances and Services unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency (EPA) for the EPA’s ToxCast screening program
AVI BioPharma Awarded up to $291 Million U.S. Government Contract
Aug 4 | Articles
AVI BioPharma, Inc. announced that it has been awarded a new contract
for up to approximately $291 million total with the U.S. Department of
Defense Chemical and Biological Defense Program through the U.S. Army
Space and Missile Defense Command for the development of the Company's
hemorrhagic fever virus therapeutic candidates, AVI-6002 and AVI-6003,
for Ebola and Marburg viruses, respectively.
Asuragen and Life Technologies Launch Leukemia Test
Aug 4 | Articles
Asuragen, Inc. and Life Technologies Corporation announced that they
have completed CE-marking and commercial launch in Europe of the
BCR/ABL1 Quant Test, Asuragen's clinically validated and cGMP
manufactured test intended to aid clinicians in the monitoring and
treatment of individuals afflicted with chronic myeloid leukemia (CML)
Merck KGaA acquires Millipore
Mar 1 | News
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 billion (US$ 7.2 billion).
Slowing Evolution to Stop Drug Resistance
Nov 19 2009 | News
Infectious organisms that become resistant to antibiotics are a serious threat to human society. They are also a natural part of evolution. In a new project, researchers at the University of Gothenburg are attempting to find substances that can slow the pace of evolution, in order to ensure that the drugs of today remain effective into the future.
Fine Tuning Treatments for Depression
Oct 19 2009 | News
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated – a finding that may help fine-tune therapies for depression.
A Flash of Inspiration
Oct 13 2009 | Bioscience Technology Blog
According to IBM, DNA origami causes single DNA molecules to self assemble in solution via a reaction between a long single strand of viral DNA and a mixture of different short synthetic oligonucleotide strands.